Startseite
Impressum
Datenschutz
 
 
  SPOT ON
 

Antithrombotic triple therapy

 
  THERAPY FROM A CRITICAL VIEWPOINT
 

New data on HPV vaccines

Tight blood sugar control in type 2 diabetes?

 
  a-t READER'S QUESTIONS AND COMMENTS
 

UKPDS follow-up: consequences for the treatment of diabetes

INTANZA: a new intradermal influenza vaccine

Generics in the patent trap

 
  IN BRIEF
 

Quality tests of citalopram preparations (CIPRAMIL, generics)

 
  CURRENT ADR NETWORK REPORT
 

Paraesthesia due to angiotensin-II receptor antagonists

 
  SIDE EFFECTS
 

Omalizumab (XOLAIR): cardiovascular ADR

 
© arznei-telegramm 8/2009